◀ Back to EGF
EGF — ELK1
Text-mined interactions from Literome
Wong et al., J Biol Chem 1999
:
Conversely, overexpression of ErbB2- ( 1-813 ) inhibited
EGF stimulated
Elk-1 transactivation in c'1000 but not in WT cells
Groot et al., Eur J Cell Biol 2000
(Insulinoma...) :
In INS-1 cells, however, the activity of the
GAL4-Elk1 fusion protein was
induced by NGF, but not by
EGF
Bernal-Mizrachi et al., Am J Physiol Endocrinol Metab 2001
(Insulinoma) :
EGF induced
activation of
Elk-1 was also inhibited by PD98059 ( 60 +/- 5 % )
Tyagi et al., Oncogene 2003
(Adenocarcinoma...) :
GSE treatment of cells also inhibited both
EGF induced and constitutively active
Elk1 phosphorylation and AP1 activation
Kolli et al., J Biol Chem 2004
:
Using MVP-deficient fibroblasts, we demonstrate that MVP cooperates with Ras for optimal
EGF induced
Elk-1 activation and is required for cell survival
Mahimainathan et al., American journal of physiology. Renal physiology 2005
:
In addition to activating PI3-kinase signaling,
EGF increased Erk1/2 MAPK activity, leading to transcriptional activation of its nuclear target
Elk-1 and resulting in c-fos expression
Bennett et al., Mol Cell Biol 1996
:
An SHPTP2 mutant with both C-terminal tyrosyl phosphorylation sites converted to phenylalanine ( PTP2YF ) was also without effect ; moreover, PTP2YF rescued PTP2CS induced inhibition of
EGF induced
Elk-1 transactivation